Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Dec;102(Suppl 11):107–110. doi: 10.1289/ehp.94102s11107

Pharmacokinetics in the infant.

R L Milsap 1, W J Jusko 1
PMCID: PMC1566769  PMID: 7737034

Abstract

Processes controlling the absorption, distribution, metabolism, excretion, and pharmacologic effects of drugs are likely to be immature or altered in neonates and infants. Absorption may be affected by differences in gastric pH and stomach emptying rate. Low serum protein concentrations and higher body water composition can change drug distribution. Drug metabolism enzyme activity is typically reduced in the neonate, but rapidly develops over the first year of life. Renal excretion mechanisms are low at birth, but mature over a few months. Limited data are available on the pharmacodynamics of drugs; infants show greater sensitivity to d-tubocurarine. Developmental changes are rapid during the first weeks and months of life, thus requiring continual modification of drug dosage regimens designed for treating pediatric patients.

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agunod M., Yamaguchi N., Lopez R., Luhby A. L., Glass G. B. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis. 1969 Jun;14(6):400–414. doi: 10.1007/BF02239360. [DOI] [PubMed] [Google Scholar]
  2. Aranda J. V., MacLeod S. M., Renton K. W., Eade N. R. Hepatic microsomal drug oxidation and electron transport in newborn infants. J Pediatr. 1974 Oct;85(4):534–542. doi: 10.1016/s0022-3476(74)80465-8. [DOI] [PubMed] [Google Scholar]
  3. Aranda J. V., Stern L. Clinical aspects of developmental pharmacology and toxicology. Pharmacol Ther. 1983;20(1):1–51. doi: 10.1016/0163-7258(83)90044-x. [DOI] [PubMed] [Google Scholar]
  4. Arant B. S., Jr Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr. 1978 May;92(5):705–712. doi: 10.1016/s0022-3476(78)80133-4. [DOI] [PubMed] [Google Scholar]
  5. Arant B. S., Jr Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr. 1978 May;92(5):705–712. doi: 10.1016/s0022-3476(78)80133-4. [DOI] [PubMed] [Google Scholar]
  6. Assael B. M. Pharmacokinetics and drug distribution during postnatal development. Pharmacol Ther. 1982;18(2):159–197. doi: 10.1016/0163-7258(82)90066-3. [DOI] [PubMed] [Google Scholar]
  7. Avery G. B., Randolph J. G., Weaver T. Gastric acidity in the first day of life. Pediatrics. 1966 Jun;37(6):1005–1007. [PubMed] [Google Scholar]
  8. Ballard P. L. Glucocorticoid receptors in the lung. Fed Proc. 1977 Dec;36(13):2660–2665. [PubMed] [Google Scholar]
  9. Bartels H. Drug therapy in childhood: what has been done and what has to be done? Pediatr Pharmacol (New York) 1983;3(3-4):131–143. [PubMed] [Google Scholar]
  10. Besunder J. B., Reed M. D., Blumer J. L. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin Pharmacokinet. 1988 Apr;14(4):189–216. doi: 10.2165/00003088-198814040-00001. [DOI] [PubMed] [Google Scholar]
  11. Besunder J. B., Reed M. D., Blumer J. L. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II). Clin Pharmacokinet. 1988 May;14(5):261–286. doi: 10.2165/00003088-198814050-00001. [DOI] [PubMed] [Google Scholar]
  12. Birnbaum L. S. Pharmacokinetic basis of age-related changes in sensitivity to toxicants. Annu Rev Pharmacol Toxicol. 1991;31:101–128. doi: 10.1146/annurev.pa.31.040191.000533. [DOI] [PubMed] [Google Scholar]
  13. Bonati M., Latini R., Marra G., Assael B. M., Parini R. Theophylline metabolism during the first month of life and development. Pediatr Res. 1981 Apr;15(4 Pt 1):304–308. doi: 10.1203/00006450-198104000-00003. [DOI] [PubMed] [Google Scholar]
  14. Brodersen R., Friis-Hansen B., Stern L. Drug-induced displacement of bilirubin from albumin in the newborn. Dev Pharmacol Ther. 1983;6(4):217–229. doi: 10.1159/000457308. [DOI] [PubMed] [Google Scholar]
  15. Dutton G. J. Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu Rev Pharmacol Toxicol. 1978;18:17–35. doi: 10.1146/annurev.pa.18.040178.000313. [DOI] [PubMed] [Google Scholar]
  16. Evans N. J., Rutter N., Hadgraft J., Parr G. Percutaneous administration of theophylline in the preterm infant. J Pediatr. 1985 Aug;107(2):307–311. doi: 10.1016/s0022-3476(85)80157-8. [DOI] [PubMed] [Google Scholar]
  17. Feldman R. D., Limbird L. E., Nadeau J., Robertson D., Wood A. J. Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med. 1984 Mar 29;310(13):815–819. doi: 10.1056/NEJM198403293101303. [DOI] [PubMed] [Google Scholar]
  18. Fisher D. M., O'Keeffe C., Stanski D. R., Cronnelly R., Miller R. D., Gregory G. A. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology. 1982 Sep;57(3):203–208. doi: 10.1097/00000542-198209000-00009. [DOI] [PubMed] [Google Scholar]
  19. Friis-Hansen B. Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics. 1971 Jan;47(1 Suppl):264+–264+. [PubMed] [Google Scholar]
  20. Giacoia G. P. The future of neonatal therapeutic drug monitoring. Ther Drug Monit. 1990 Jul;12(4):311–315. doi: 10.1097/00007691-199007000-00002. [DOI] [PubMed] [Google Scholar]
  21. Gilman J. T. Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications. Clin Pharmacokinet. 1990 Jul;19(1):1–10. doi: 10.2165/00003088-199019010-00001. [DOI] [PubMed] [Google Scholar]
  22. Guignard J. P., Torrado A., Da Cunha O., Gautier E. Glomerular filtration rate in the first three weeks of life. J Pediatr. 1975 Aug;87(2):268–272. doi: 10.1016/s0022-3476(75)80600-7. [DOI] [PubMed] [Google Scholar]
  23. Heimann G. Enteral absorption and bioavailability in children in relation to age. Eur J Clin Pharmacol. 1980 Jul;18(1):43–50. doi: 10.1007/BF00561477. [DOI] [PubMed] [Google Scholar]
  24. Herngren L., Ehrnebo M., Boréus L. O. Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol. Dev Pharmacol Ther. 1983;6(2):110–124. doi: 10.1159/000457284. [DOI] [PubMed] [Google Scholar]
  25. Hook J. B., Hewitt W. R. Development of mechanisms for drug excretion. Am J Med. 1977 Apr;62(4):497–506. doi: 10.1016/0002-9343(77)90404-1. [DOI] [PubMed] [Google Scholar]
  26. Horning M. G., Butler C. M., Howlin J., Hill R. M. Drug metabolism in the human neonate. Life Sci. 1975 Mar 1;16(5):651–671. doi: 10.1016/0024-3205(75)90343-4. [DOI] [PubMed] [Google Scholar]
  27. Janicke D. M., Rubio T. T., Wirth F. H., Jr, Karotkin E. H., Jusko W. J. Developmental pharmacokinetics of mezlocillin in newborn infants. J Pediatr. 1984 May;104(5):773–781. doi: 10.1016/s0022-3476(84)80966-x. [DOI] [PubMed] [Google Scholar]
  28. Jungbluth G. L., Wirth F. H., Jr, Rubio T. T., Janicke D. M., Jusko W. J. Developmental pharmacokinetics of mezlocillin in 4 newborn infants. Dev Pharmacol Ther. 1988;11(6):317–321. doi: 10.1159/000457710. [DOI] [PubMed] [Google Scholar]
  29. Jusko W. J., Khanna N., Levy G., Stern L., Yaffe S. J. Riboflavin absorption and excretion in the neonate. Pediatrics. 1970 Jun;45(6):945–949. [PubMed] [Google Scholar]
  30. Kearns G. L., Reed M. D. Clinical pharmacokinetics in infants and children. A reappraisal. Clin Pharmacokinet. 1989;17 (Suppl 1):29–67. doi: 10.2165/00003088-198900171-00005. [DOI] [PubMed] [Google Scholar]
  31. Kuhn R. J., Nahata M. C., Powell D. A., Bickers R. G. Pharmacokinetics of netilmicin in premature infants. Eur J Clin Pharmacol. 1986;29(5):635–637. doi: 10.1007/BF00635907. [DOI] [PubMed] [Google Scholar]
  32. Lares-Asseff I., Cravioto J., Santiago P., Pérez-Ortíz B. Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children. Clin Pharmacol Ther. 1992 Jan;51(1):42–50. doi: 10.1038/clpt.1992.6. [DOI] [PubMed] [Google Scholar]
  33. Levy G., Khanna N. N., Soda D. M., Tsuzuki O., Stern L. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics. 1975 Jun;55(6):818–825. [PubMed] [Google Scholar]
  34. McFadden S. W., Haddow J. E. Coma produced by topical application of isopropanol. Pediatrics. 1969 Apr;43(4):622–623. [PubMed] [Google Scholar]
  35. Mirkin B. L. Ontogenesis of the adrenergic nervous system: functional and pharmacologic implications. Fed Proc. 1972 Jan-Feb;31(1):65–73. [PubMed] [Google Scholar]
  36. Morselli P. L. Clincial pharmacokinetics in neonates. Clin Pharmacokinet. 1976;1(2):81–98. doi: 10.2165/00003088-197601020-00001. [DOI] [PubMed] [Google Scholar]
  37. Morselli P. L. Clinical pharmacology of the perinatal period and early infancy. Clin Pharmacokinet. 1989;17 (Suppl 1):13–28. doi: 10.2165/00003088-198900171-00004. [DOI] [PubMed] [Google Scholar]
  38. Morselli P. L., Franco-Morselli R., Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet. 1980 Nov-Dec;5(6):485–527. doi: 10.2165/00003088-198005060-00001. [DOI] [PubMed] [Google Scholar]
  39. Murphy G. M., Signer E. Bile acid metabolism in infants and children. Gut. 1974 Feb;15(2):151–163. doi: 10.1136/gut.15.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nahata M. C., Powell D. A., Durrell D. E., Miller M. C., Glazer J. P. Effect of gestational age and birth weight on tobramycin kinetics in newborn infants. J Antimicrob Chemother. 1984 Jul;14(1):59–65. doi: 10.1093/jac/14.1.59. [DOI] [PubMed] [Google Scholar]
  41. Neims A. H., Warner M., Loughnan P. M., Aranda J. V. Developmental aspects of the hepatic cytochrome P450 monooxygenase system. Annu Rev Pharmacol Toxicol. 1976;16:427–445. doi: 10.1146/annurev.pa.16.040176.002235. [DOI] [PubMed] [Google Scholar]
  42. Phelps S. J., Evans W. E., Chesney R. W. Advances in pediatric pharmacokinetics and therapeutics. J Pediatr. 1990 Dec;117(6):996–1001. doi: 10.1016/s0022-3476(05)80154-4. [DOI] [PubMed] [Google Scholar]
  43. Rane A., Wilson J. T. Clinical pharmacokinetics in infants and children. Clin Pharmacokinet. 1976;1(1):2–24. doi: 10.2165/00003088-197601010-00002. [DOI] [PubMed] [Google Scholar]
  44. Redmond G. P., Bell J. J., Nichola P. S., Perel J. M. Effect of growth hormone on human drug metabolism: time course and substrate specificity. Pediatr Pharmacol (New York) 1980;1(1):63–70. [PubMed] [Google Scholar]
  45. Signer E. Gastric emptying in newborns and young infants. Measurement of the rate of emptying using indium-113m-microcolloid. Acta Paediatr Scand. 1975 May;64(3):525–530. doi: 10.1111/j.1651-2227.1975.tb03874.x. [DOI] [PubMed] [Google Scholar]
  46. Silverio J., Poole J. W. Serum concentrations of ampicillin in newborn infants after oral administration. Pediatrics. 1973 Mar;51(3):578–580. [PubMed] [Google Scholar]
  47. Szefler S. J., Koup J. R., Giacoia G. P. Paradoxical behavior of serum digoxin concentrations in an anuric neonate. J Pediatr. 1977 Sep;91(3):487–489. doi: 10.1016/s0022-3476(77)81331-0. [DOI] [PubMed] [Google Scholar]
  48. Tserng K. Y., King K. C., Takieddine F. N. Theophylline metabolism in premature infants. Clin Pharmacol Ther. 1981 May;29(5):594–600. doi: 10.1038/clpt.1981.83. [DOI] [PubMed] [Google Scholar]
  49. Tyrala E. E., Hillman L. S., Hillman R. E., Dodson W. E. Clinical pharmacology of hexachlorophene in newborn infants. J Pediatr. 1977 Sep;91(3):481–486. doi: 10.1016/s0022-3476(77)81330-9. [DOI] [PubMed] [Google Scholar]
  50. Walson P. D., Edwards R., Cox S. Neonatal therapeutic drug monitoring--its clinical relevance. Ther Drug Monit. 1989;11(4):425–430. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES